MedPath

Individual Dietary Counseling Based on Taste-tests in Patients With Hematological Cancer in Cytostatic Therapy

Not Applicable
Conditions
Hematological Malignancy
Interventions
Other: Standard care
Dietary Supplement: Taste-test
Registration Number
NCT05364359
Lead Sponsor
University of Copenhagen
Brief Summary

The purpose of the study is to investigate whether a simple taste-test will increase the intake of energy as part of the individual dietary counseling.

Detailed Description

The investigators will investigate the tastes (umami, bitter, salty, sweet and sour) that the patients prefers in order to increase the energy intake and reduce the risk of weight loss and loss of fat-free mass for patients with hematological cancer.

The study will be conducted as a single blinded randomized controlled trial. 40 patients will be recruited, and will be divided into two groups; the intervention group and the control group. The patients will not know which group they belong to.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria
  • 18 years or older
  • Able to understand the "Participant Information" paper
  • Diagnosed with hematological cancer
  • Must be undergoing chemotherapy (at least one treatment during the study)
  • Outpatient
  • Be able to take pictures of meals (and send to the sub-investigators)
  • Be able to speak and read the danish language
Exclusion Criteria
  • Pacemaker

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Standard dietary counselingStandard careThe patients will receive a individual standard dietary counseling not based on the taste-test
Intervention groupTaste-testThe patients will receive a individual dietary counseling based on the taste-test
Primary Outcome Measures
NameTimeMethod
Consumption of energy as a percentage of estimated need6 weeks

difference - before and after intervention

Secondary Outcome Measures
NameTimeMethod
Hand-grip-strength (measured with a dynamometer)6 weeks

difference - before and after intervention

Body weight6 weeks

difference - before and after intervention

Fat-free-mass and fat-mass in percent (bioimpedance measurement)6 weeks

difference - before and after intervention

Satisfaction (measured with EROTC QLQ-C30 version 3.0)6 weeks

difference - before and after intervention. Higher scores means worse outcome. Lower scores means better outcomes.

Protein intake6 weeks

difference - before and after intervention

Burning/pain in the mouth (measured on a scale)6 weeks

difference - before and after intervention measured with Likert scale (1 to 5). Higher scores means a worse outcome. Lower scores means better outcomes.

Trial Locations

Locations (1)

Department of Hematology

🇩🇰

Roskilde, Denmark

© Copyright 2025. All Rights Reserved by MedPath